Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral contraceptive for dysmenorrhea in endometriosis
NCT00212277Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Feb 2005
- Primary completion
- Sep 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of norethindrone, ethinyl estradiol in dysmenorrhea, sponsored by Nobelpharma Co., Ltd.. Started Feb 2005; status: completed.
02
Drugs
norethindroneethinyl estradiol
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT00212277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212277.